Know Labs (OTCMKTS:KNWN – Get Rating) is one of 28 publicly-traded companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it compare to its competitors? We will compare Know Labs to similar companies based on the strength of its analyst recommendations, valuation, profitability, earnings, institutional ownership, risk and dividends.
Insider & Institutional Ownership
10.6% of Know Labs shares are held by institutional investors. Comparatively, 61.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are held by institutional investors. 44.0% of Know Labs shares are held by insiders. Comparatively, 16.1% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
This table compares Know Labs and its competitors revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Know Labs||$120,000.00||-$25.36 million||-1.99|
|Know Labs Competitors||$2.66 billion||$435.24 million||9.77|
Know Labs’ competitors have higher revenue and earnings than Know Labs. Know Labs is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
Know Labs has a beta of 3.04, meaning that its share price is 204% more volatile than the S&P 500. Comparatively, Know Labs’ competitors have a beta of 1.03, meaning that their average share price is 3% more volatile than the S&P 500.
This is a summary of recent recommendations for Know Labs and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Know Labs Competitors||154||684||949||28||2.47|
Know Labs currently has a consensus price target of $7.00, indicating a potential upside of 340.25%. As a group, “Measuring & controlling devices, not elsewhere classified” companies have a potential upside of 28.72%. Given Know Labs’ stronger consensus rating and higher possible upside, equities analysts clearly believe Know Labs is more favorable than its competitors.
This table compares Know Labs and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Know Labs Competitors||-3,288.15%||5.20%||2.16%|
Know Labs competitors beat Know Labs on 7 of the 13 factors compared.
Know Labs Company Profile (Get Rating)
Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Receive News & Ratings for Know Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Know Labs and related companies with MarketBeat.com's FREE daily email newsletter.